About Aleafiaa Pharmaceuticals Private Limited
Data last updated:
Aleafiaa Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC301818. Its GSTIN is 27AAQCA4224R1Z1 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.08 Lakh. It is led by directors Priyadarsini Akshya Kandula and Akshya Kumar Mahapatra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No.408 Lodha Supremus 2 Wagle Estate, Thane, Maharashtra, India – 400604.
As per the financials filed for FY 2024, the company reported a revenue of ₹17 Lakh. For the same year it recorded a net profit of ₹17,023 (net margin 1%) and EBITDA of ₹17,023 (EBITDA margin 1%).
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website akums.in.
Company details
Contact details
Aleafiaa Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is akums.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No.408 Lodha Supremus 2 Wagle Estate, Thane, Maharashtra, India – 400604
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aleafiaa Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aleafiaa Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Aleafiaa Pharmaceuticals Private Limited, buy the company report.
Financials of Aleafiaa Pharmaceuticals Private Limited
FY 2025 filings availableAleafiaa Pharmaceuticals Private Limited reported revenue of ₹17 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17,023 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17,023 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aleafiaa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aleafiaa Pharmaceuticals Private Limited
Aleafiaa Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyadarsini Akshya Kandula | Director | 15 Nov 2017 | 8 Years 11 Months | Current |
| Akshya Kumar Mahapatra | Director | 17 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Aleafiaa Pharmaceuticals Private Limited is audited by VIBHOR GUPTA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIBHOR GUPTA & ASSOCIATES | FY 2020 | 022402N |
Shareholding
The shareholding of Aleafiaa Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Aleafiaa Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aleafiaa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aleafiaa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aleafiaa Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAQCA4224R1Z1 | Maharashtra | Active | 20 Jul 2018 |
To see the full GST registrations and return filing status of Aleafiaa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aleafiaa Pharmaceuticals Private Limited has 8 board changes on record since 2017: 5 appointments and 3 cessations. The latest: Arushi Jain ceased to be Director on 30 Mar 2021.
Frequently asked questions
Aleafiaa Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 November 2017 (9+ years old) and is registered under CIN U74999MH2017PTC301818.
Aleafiaa Pharmaceuticals has 2 current directors:
- Priyadarsini Akshya Kandula - Director
- Akshya Kumar Mahapatra - Director
The latest financial statements of Aleafiaa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Aleafiaa Pharmaceuticals is 27AAQCA4224R1Z1, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aleafiaa Pharmaceuticals is U74999MH2017PTC301818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aleafiaa Pharmaceuticals was incorporated on 15 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Arushi Jain ceased to be Director on 30 Mar 2021. Kanishk Jain ceased to be Director on 30 Mar 2021. Akshya Kumar Mahapatra was appointed as Director on 17 Jan 2019. Aleafiaa Pharmaceuticals has 8 board changes on record in total.
Aleafiaa Pharmaceuticals can be reached through the website akums.in. Its registered office is in Thane, Maharashtra, India.
The registered office of Aleafiaa Pharmaceuticals is at Office No.408 Lodha Supremus 2 Wagle Estate, Thane, Maharashtra, India – 400604.
Aleafiaa Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
